Inhibiting miR‐27a and miR‐142‐5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway
- 30 December 2019
- journal article
- research article
- Published by Wiley in IUBMB Life
- Vol. 72 (3) , 361-372
Abstract
Summary: The gene Nrf2 (nuclear factor‐erythroid 2‐related factor 2) is the most important regulator of the cellular antioxidant system and its dysregulation has a role in the etiology of nonalcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the association between Nrf2 targeted miRNAs (miR‐27a, miR‐142‐5p, miR‐153, and miR‐128) with lipid accumulation in vitro and in vivo models of NAFLD. We used two in vivo and in vitro models of NAFLD. The expression of the genes and miRNAs was assessed by real‐time PCR and the protein level was evaluated using western blot. To investigate the potential role of miRNAs in NAFLD, the inhibitors or mimics of the miR‐27a and miR‐142‐5p were transfected into HepG2 cells. The mRNA and protein levels of Nrf2 were significantly decreased in the liver of high fat diet‐fed mice as well as in HepG2 cells treated with high glucose (HG). Reduced expression of Nrf2 was associated with increased expression levels of miR‐27a and miR‐142‐5p in both models of NAFLD. HG‐induced triglyceride accumulation was attenuated by inhibition of miR‐27a or miR‐142‐5p in HepG2 cells. Overexpression of miR‐27a or miR‐142‐5p suppressed the expression of Nrf2 and its downstream antioxidant genes and increased production of reactive oxygen species, whereas inhibition of miR‐27a or miR‐142‐5p reversed these effects. In conclusion, the data of this study may suggest that miR‐27a and miR‐142‐5p are increased in NAFLD, where they suppress Nrf2 expression and contribute to the accumulation of lipids in the hepatocytes.Keywords
Funding Information
- Tehran University of Medical Sciences and Health Services (grant 96‐01‐30‐33971)
This publication has 43 references indexed in Scilit:
- The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trialActa Diabetologica, 2018
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver DiseaseOxidative Medicine and Cellular Longevity, 2018
- Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complicationsClinica Chimica Acta, 2016
- Non Alcoholic Fatty Liver: Epidemiology and Natural HistoryReviews on Recent Clinical Trials, 2015
- The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid MetabolismBioMed Research International, 2015
- Role of Nrf2 in chronic liver diseaseWorld Journal of Gastroenterology, 2014
- Hepatic insulin resistance, metabolic syndrome and cardiovascular diseaseClinical Biochemistry, 2009
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Identification of the NF-E2-related Factor-2-dependent Genes Conferring Protection against Oxidative Stress in Primary Cortical Astrocytes Using Oligonucleotide Microarray AnalysisJournal of Biological Chemistry, 2003
- Prevalence of the Metabolic Syndrome Among US AdultsJAMA, 2002